Tech Company M&A Transactions

Asklepios BioPharmaceutical Acquisition

Asklepios BioPharmaceutical was purchased by Bayer AG. The transaction occurred on 10/26/2020. The transaction price was $4 billion.

Transaction Overview

Acquired By
Announced On
Transaction Type
M&A Terms
Bayer will pay an upfront consideration of USD 2 billion and potential success-based milestone payments of up to USD 2 billion.

Company Information

Company Status
Acquired or Merged
Mailing Address
20 T.W. Alexander 110
Research Triangle Park, NC 27709
Email Address
Asklepios BioPharmaceutical, Inc. (AskBio) is a privately held AAV gene therapy based company founded in 2001 to advance the work of Dr. Richard Jude Samulski, former Director of the Gene Therapy Center at the University of North Carolina (UNC) from the lab into the clinic. Dr. Samulski was the first to clone AAV for therapeutic purposes.
Asklepios BioPharmaceutical LinkedIn Company Profile
Social Media
Asklepios BioPharmaceutical Company Twitter Account
Company News
Asklepios BioPharmaceutical News
Asklepios BioPharmaceutical on Facebook
Asklepios BioPharmaceutical on YouTube

Management Team

Email & Social
Chief Executive Officer
Sheila Mikhail
  Sheila Mikhail LinkedIn Profile  Sheila Mikhail Twitter Account  Sheila Mikhail News  Sheila Mikhail on Facebook
Chief Medical Officer
Martin Childers
  Martin Childers LinkedIn Profile  Martin Childers Twitter Account  Martin Childers News  Martin Childers on Facebook
Chief Operating Officer
Robert King
  Robert King LinkedIn Profile  Robert King Twitter Account  Robert King News  Robert King on Facebook
Chief Scientific Officer
Philippe Moullier
  Philippe Moullier LinkedIn Profile  Philippe Moullier Twitter Account  Philippe Moullier News  Philippe Moullier on Facebook
Chief Technical Officer
Josh Grieger
  Josh Grieger LinkedIn Profile  Josh Grieger Twitter Account  Josh Grieger News  Josh Grieger on Facebook
Richard Samulski
  Richard Samulski LinkedIn Profile  Richard Samulski Twitter Account  Richard Samulski News  Richard Samulski on Facebook
VP - Regulatory Affairs
Diane Balderson
  Diane Balderson LinkedIn Profile  Diane Balderson Twitter Account  Diane Balderson News  Diane Balderson on Facebook



Browse more venture capital transactions:

Prev: 10/26/2020: Linktree venture capital transaction
Next: 10/27/2020: KETOS venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary